Antidepressant Treatment of Fibromyalgia: A Meta-Analysis and Review

Wolfe, 1990, The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multienter Criteria Committee, Arthritis Rheum, 33, 160, 10.1002/art.1780330203 Hudson, 1996, The relationship between fibromyalgia and major depressive disorder, Rheum Dis Clin North Am, 22, 285, 10.1016/S0889-857X(05)70273-8 Wolfe, 1995, The prevalence and characteristics of fibromyalgia in the general population, Arthritis Rheum, 38, 19, 10.1002/art.1780380104 Simms, 1994, Controlled trials of therapy in fibromyalgia syndrome, Baillieres Clin Rheumatol, 8, 917, 10.1016/S0950-3579(05)80054-8 Goldenberg, 1989, A review of the role of tricyclic medications in the treatment of fibromyalgia syndrome, J Rheumatol, 16, 137 Godfrey, 1996, A guide to the understanding and use of tricyclic antidepressants in the overall management of fibromyalgia and other chronic pain syndromes, Arch Intern Med, 156, 1047, 10.1001/archinte.1996.00040041047001 Moldofsky, 1975, Musculoskeletal symptoms and non-REM sleep disturbance in patients with “fibrositis syndrome” and healthy subjects, Psychosom Med, 37, 341, 10.1097/00006842-197507000-00008 Moldofsky, 1975, Induction of neurasthenic musculoskeletal pain syndrome by selective sleep stage deprivation, Psychosom Med, 38, 35, 10.1097/00006842-197601000-00006 Sicuteri, 1972, Headache as a possible expression of deficiency of brain 5-hydroxytryptamine (central denervation sensitivity), Psychosom Med, 12, 69 Gruber, 1996, The management of treatment-resistant depression in disorders on the interface of psychiatry and medicine: fibromyalgia, chronic fatigue syndrome, migraine, irritable bowel syndrome, atypical facial pain, and premenstrual dysphoric disorder, Psychiatr Clin North Am, 19, 351, 10.1016/S0193-953X(05)70292-6 Buchwald, 1994, Comparison of patients with chronic fatigue syndrome, fibromyalgia and multiple chemical sensitivities, Arch Intern Med, 154, 2049, 10.1001/archinte.1994.00420180053007 Buchwald, 1987, The “chronic, active Epstein-Barr virus infection” syndrome and primary fibromyalgia, Arthritis Rheum, 20, 1132, 10.1002/art.1780301007 Goldenberg, 1988, Fibromyalgia and other chronic fatigue syndromes: is there evidence for chronic viral disease?, Semin Arthritis Rheum, 18, 111, 10.1016/0049-0172(88)90003-0 Yunus, 1989, A controlled study of primary fibromyalgia syndrome: clinical features and association with other functional syndromes, J Rheumatol, 16, 62 Cassidy, 1957, Clinical observations in manic-depression illness: a quantitative study on one hundred manic-depressive patients and fifty medically sick controls, JAMA, 153, 1535, 10.1001/jama.1957.02980140011003 Mezzich, 1980, Depressive symptomatology across the Americas, Arch Gen Psychiatry, 37, 818, 10.1001/archpsyc.1980.01780200096012 Stoeckle, 1962, Bodily complaints and other symptoms of depressive reaction, JAMA, 180, 134, 10.1001/jama.1962.03050150040008 Burckhardt, 1990, Psychological status of women with fibromyalgia (FMS), Arthritis Rheum, 33, S136 Goldenberg, 1986, Psychological studies in fibrositis, Am J Med, 81, 67, 10.1016/0002-9343(86)90879-X Hudson, 1992, Comorbidity of fibromyalgia with medical and psychiatric disorders, Am J Med, 92, 363, 10.1016/0002-9343(92)90265-D Hudson, 1985, Fibromyalgia and major affective disorder: a controlled phenomenology and family history study, Am J Psychiatry, 142, 441, 10.1176/ajp.142.4.441 Tariot, 1986, Psychiatric disorders in fibromyalgia, Am J Psychiatry, 143, 813, 10.1176/ajp.143.6.812-b Walker, 1997, Psychosocial factors in fibromyalgia and rheumatoid arthritis, I: psychiatric diagnoses and functional disability, Psychosom Med, 59, 565, 10.1097/00006842-199711000-00002 Ahles, 1991, Psychiatric status of patients with primary fibromyalgia, patients with rheumatoid arthritis, and subjects without pain: a blind comparison of DSM-III diagnoses, Am J Psychiatry, 148, 1721, 10.1176/ajp.148.12.1721 Kirmayer, 1985, Somatization and depression in fibromyalgia syndrome, Am J Psychiatry, 145, 950 Alfici, 1989, Primary fibromyalgia syndrome—a variant of depressive disorder?, Psychother Psychosom, 51, 156, 10.1159/000288150 Bouckons, 1996, Chronic pain: neuropsychopharmacology and adjunctive psychiatric treatment, 1006 Frank, 1988, Antidepressant analgesia in rheumatoid arthritis, J Rheumatol, 15, 1632 Alarcon, 1998, Advances in the treatment of fibromyalgia: current status and future directions, Am J Med Sci, 315, 397, 10.1097/00000441-199806000-00008 Goldenberg, 1986, A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia, Arthritis Rheum, 29, 1371, 10.1002/art.1780291110 Carette, 1986, Evaluation of amitriptyline in primary fibrositis: a double-blind, placebo-controlled study, Arthritis Rheum, 29, 655, 10.1002/art.1780290510 Bibolotti, 1986, The management of fibrositis: a double-blind comparison of maprotiline (Ludiomil), chlorimipramine, and placebo, J Clin Trials, 23, 269 Caruso, 1987, Double-blind study of dothiepin versus placebo in the treatment of primary fibromyalgia syndrome, J Int Med Res, 15, 154, 10.1177/030006058701500305 Scudds, 1989, Improvements in pain responsiveness in patients with fibrositis after successful treatment with amitriptyline, J Rheumatol, 16, 98 Hench, 1989, Fibromyalgia: effects of temazepam, amitriptyline and placebo on pain and sleep, Sleep Res, 18, 335 Jaeschke, 1991, Clinical usefulness of amitriptyline in fibromyalgia: the results of 23 N-of-1 randomized controlled trials, J Rheumatol, 18, 447 Carette, 1994, Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia: a randomized, double-blind clinical trial, Arthritis Rheum, 37, 32, 10.1002/art.1780370106 Carette, 1995, Sleep electroencephalography and the clinical response to amitriptyline in patients with fibromyalgia, Arthritis Rheum, 38, 1211, 10.1002/art.1780380906 Goldenberg, 1996, A randomized double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia, Arthritis Rheum, 39, 1852, 10.1002/art.1780391111 Bennett, 1988, A comparison of cyclobenzaprine and placebo in the management of fibrositis, Arthritis Rheum, 31, 1535, 10.1002/art.1780311210 Quimby, 1989, A randomized trial of cyclobenzaprine for the treatment of fibromyalgia, J Rheumatol, 16, 140 Reynolds, 1991, The effects of cyclobenzaprine on sleep physiology and symptoms in patients with fibromyalgia, J Rheumatol, 18, 452 Simms, 1991, Development of preliminary criteria for response to treatment in fibromyalgia syndrome, J Rheumatol, 18, 1558 Cantini, 1994, Fluoxetine associata a ciclobenzaprina nel trattamentao della fibromialgia, Minerva Med, 85, 97 Santandrea, 1993, A double-blind crossover study of two cyclobenzaprine regimens in primary fibromyalgia syndrome, J Int Med Res, 21, 74, 10.1177/030006059302100202 Smythe, 1981, Fibrositis and other diffuse musculoskeletal syndromes, 485 Campbell, 1983, Clinical characteristics of fibrositis, I: a “blinded” controlled study of symptoms and tender points, Arthritis Rheum, 26, 817, 10.1002/art.1780260701 Cedarbaum, 1990, Drugs for Parkinson's disease, spasticity, and acute muscle spasms, 463 Harsch, 1984, Mania in two patients following cyclobenzaprine, Psychosomatics, 25, 791, 10.1016/S0033-3182(84)72967-7 Barnes, 1980, Brain stem noradrenergic system depression by cyclobenzaprine, Neuropharmacology, 19, 221, 10.1016/0028-3908(80)90142-2 Share, 1975, Cyclobenzaprine: a novel centrally acting skeletal muscle relaxant, Neuropharmacology, 14, 675, 10.1016/0028-3908(75)90091-X Kobayashi, 1996, Cyclobenzaprine, a centrally acting muscle relaxant, acts on descending serotonergic systems, Eur J Pharmacol, 311, 29, 10.1016/0014-2999(96)00402-5 Lang, 1983, Cyclobenzaprine effects on locus coeruleus cells in tissue slice, Neuropharmacology, 22, 249, 10.1016/0028-3908(83)90017-5 Cohen, 1988 Kalaian, 1996, A multivariate mixed linear model for meta-analysis, Psychological Methods, 1, 227, 10.1037/1082-989X.1.3.227 Matt, 1988, Threats to the validity of research syntheses Yunus, 1981, Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls, Semin Arthritis Rheum, 11, 151, 10.1016/0049-0172(81)90096-2 Smythe, 1997, Two contributions to understanding of the “fibrositis” syndrome, Bull Rheum Dis, 28, 928 Wolfe, 1994, A double-blind placebo controlled trial of fluoxetine in fibromyalgia, Scand J Rheumatol, 23, 255, 10.3109/03009749409103725 Njrregard, 1995, A randomized controlled trial of citalopram in the treatment of fibromyalgia, Pain, 61, 445, 10.1016/0304-3959(94)00218-4 Ekselius, 1997, A double-blind multicenter trial comparing sertraline and citalopram in patients with major depression, Int Clin Psychopharmacol, 12, 323, 10.1097/00004850-199711000-00005 Russell, 1991, Treatment of primary fibrositis/fibromyalgia syndrome with ibuprofen and alprazolam, Arthritis Rheum, 34, 552, 10.1002/art.1780340507 Tavoni, 1987, Evaluation of S-adeno-sylmethionine in primary fibromyalgia, Am J Med, 83, 107, 10.1016/0002-9343(87)90862-X Jacobsen, 1991, Oral S-adenosylmethionine in primary fibromyalgia: double-blind clinical evaluation, Scan J Rheumatol, 20, 294, 10.3109/03009749109096803 Rickels, 1987, Alprazolam, diazepam, imipramine, and placebo in outpatients with major depression, Arch Gen Psychiatry, 44, 862, 10.1001/archpsyc.1987.01800220024005 Russell, 1986, Is there a metabolic basis for the fibrositis syndrome?, Am J Med, 81, 50, 10.1016/0002-9343(86)90874-0 Lipinski, 1984, Open trial of S-adenosylmethlonine for treatment of depression, Am J Psychiatry, 141, 448, 10.1176/ajp.141.3.448 Dwight, 1998, An open clinical trial of venlafaxine in fibromyalgia, Psychosomatics, 39, 14, 10.1016/S0033-3182(98)71375-1 Tollefson, 1998, Selective serotonin reuptake inhibitors, 219 Burke, 1995, Short-term treatment of mood disorders with standard antidepressants, 1053 Potter, 1998, Tricyclics and tetracyclics, 199 First MB, Spitzer RL, Gibbon M, et al: Structured Clinical Interview for the DSM-IV Axis I Disorders: Patient Edition (SICD-I/P, Version 2.0). New York, Biometrics Research Department, New York State Psychiatric Institute, 1995